Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules

Verma, 2012, Pneumococcal conjugate vaccine: a newer vaccine available in India, Hum Vaccin Immunother, 8, 1317, 10.4161/hv.20654

Bartlett, 2011, Diagnostic tests for agents of community-acquired pneumonia, Clin Infect Dis, S296, 10.1093/cid/cir045

Klugman, 2003, A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection, N Engl J Med, 349, 1341, 10.1056/NEJMoa035060

Madhi, 2004, A role for Streptococcus pneumoniae in virus-associated pneumonia, Nat Med, 10, 811, 10.1038/nm1077

Simonsen, 2014, Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis, Lancet Respir Med, 2, 387, 10.1016/S2213-2600(14)70032-3

Angoulvant, 2014, Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children, Clin Infect Dis, 58, 918, 10.1093/cid/ciu006

Kuo, 2011, Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine, Vaccine, 29, 5171, 10.1016/j.vaccine.2011.05.034

Hsieh, 2009, National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential, Vaccine, 27, 5513, 10.1016/j.vaccine.2009.06.091

Dagan, 2002, Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers, J Infect Dis, 185, 927, 10.1086/339525

Huang, 2009, Continued impact of pneumococcal conjugate vaccine on carriage in young children, Pediatrics, 124, e1, 10.1542/peds.2008-3099

Chen, 2012, Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan, Pediatr Infect Dis J, 31, e196, 10.1097/INF.0b013e31826eb5a7

Hsieh, 2011, Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan, Pediatr Infect Dis J, 30, 740, 10.1097/INF.0b013e31821b10c3

Lin, 2013, Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age, Pediatr Infect Dis J, 32, 419, 10.1097/INF.0b013e31828637b1

Wei, 2015, Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine, Pediatr Infect Dis J, 34, e71, 10.1097/INF.0000000000000565

Taiwan Centers for Disease Control, 2016

Su, 2016, Effectiveness of pneumococcal conjugate vaccines of different valences against invasive pneumococcal disease among children in Taiwan: a nationwide study, Pediatr Infect Dis J, 35, e124, 10.1097/INF.0000000000001054

Bartlett, 1998, Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America, Clin Infect Dis, 26, 811, 10.1086/513953

Hsieh, 2015, Increase in fitness of Streptococcus pneumoniae is associated with the severity of necrotizing pneumonia, Pediatr Infect Dis J, 34, 499, 10.1097/INF.0000000000000631

Azzari, 2010, Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease, PLoS One, 5, e9282, 10.1371/journal.pone.0009282

Park, 2010, Invasive pneumococcal infections among vaccinated children in the United States, J Pediatr, 156, 478, 10.1016/j.jpeds.2009.10.008

Ladhani, 2013, Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales, Emerg Infect Dis, 19, 61, 10.3201/eid1901.120741

Snape, 2010, Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial, Pediatr Infect Dis J, 29, e80, 10.1097/INF.0b013e3181faa6be

Dagan, 2013, Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial, Clin Infect Dis, 57, 952, 10.1093/cid/cit428

Moraga-Llop, 2016, Vaccine failures in patients properly vaccinated with 13-valent pneumococcal conjugate vaccine in Catalonia, a region with low vaccination coverage, Pediatr Infect Dis J, 35, 460, 10.1097/INF.0000000000001041

Kaplan, 2013, Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine, Pediatr Infect Dis J, 32, 203, 10.1097/INF.0b013e318275614b

Moore, 2016, Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study, Lancet Respir Med, 4, 399, 10.1016/S2213-2600(16)00052-7

Andrews, 2014, Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study, Lancet Infect Dis, 14, 839, 10.1016/S1473-3099(14)70822-9

Hsieh, 2013, Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan19F-14 (ST236), J Infect Dis, 208, 203, 10.1093/infdis/jit145

Lai, 2014, Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease, J Microbiol Immunol Infect, 47, 23, 10.1016/j.jmii.2012.08.011

Chen, 2013, Clinical manifestations and microbiology of acute otitis media with spontaneous otorrhea in children, J Microbiol Immunol Infect, 46, 382, 10.1016/j.jmii.2013.04.001

Ramsay, 2003, Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method, J Infect Dis, 188, 481, 10.1086/376997

Southern, 2007, Clin Vaccine Immunol, 14, 1328, 10.1128/CVI.00191-07